PENG Dan-dan1, NING Yun-shan1,2, LI Yan1, HONG Yan-hua2, WANG Yun-dan2, WU Fen-fang2, LI Ming1,2. Preparation of monoclonal antibodies against multiple antigens[J]. Journal of Southern Medical University, 2005, 25(01): 40-43.
[1] Loomans EE, Roelen AJ, Damme HS, et al. Assessment of the functional affinity constant of monoclonal antibodies using an improved enzyme-linked immunosorbent assay [J]. J Immunol Methods, 1995, 184: 207-17. [2] http://www.hupo.org [3] He QY, Lau GK, Zhou Y, et al. Serum biomarkers of hepatitis B virus infected liver inflammation: a proteomic study [J]. Proteomics,2003, 3(5): 666-74. [4] Chignard N, Beretta L. Proteomics for hepatocellular carcinoma marker discovery[J]. Gastroenterology, 2004, 127(5 Suppl 1): S120-5. [5] Gui JF, Liu YK, Pan BS, et al. Differential proteomic analysis of human hepatocellular carcinoma cell line metastasis-associated proteins[J]. J Cancer Res Clin Oncol, 2004, 130(10): 615-22. [6] Ning YS, Luo CL, Situ WN, et al. Generation and characterization of murine monoclonal antibodies against human plasma proteins using unknown and native multi-proteins as immunogens [J]. Acta Biochem, 2004, 36(1): 84-5. [7] 钟远辉,黄秉钦.乙肝病毒感染与肝癌关系及肝损害的临床分析[J].中山医科大学学报,2002,23(5s):117-8.Zhong YH, Huang BQ. The relation of HBV infection to the hepatocellular carcinoma and liver injury: clinical analysis of 455cases[J]. J Med Univ, 2002, 23(5s): 117-8.